Eversept Partners’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Eversept Partners’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-70,594	Closed	-$6.82M	–	76
2020 Q2	$6.82M	Buy	70,594 +42,842	+154%	+$3.57M	0.94%	28
2020 Q1	$1.3M	Buy	27,752 +6,300	+29%	+$404K	0.32%	35
2019 Q4	$1.56M	Buy	+21,452	New	+$1.3M	0.28%	57
2019 Q3	–	Sell	-56,652	Closed	-$2.84M	–	70
2019 Q2	$2.84M	Buy	56,652 +21,600	+62%	+$1.05M	0.8%	29
2019 Q1	$1.82M	Buy	+35,052	New	+$1.61M	0.53%	33
2018 Q3	–	Sell	-25,950	Closed	-$1.29M	–	81
2018 Q2	$1.29M	Sell	25,950 -16,050	-38%	-$777K	0.59%	37
2018 Q1	$2.05M	Sell	42,000 -8,000	-16%	-$416K	0.95%	25
2017 Q4	$2.1M	Buy	+50,000	New	+$1.93M	1.21%	22

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Eversept Partners's MYOK Position: Q3 2020 in Review

Eversept Partners sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 70,594 shares — an estimated $6.82M sold.

Eversept Partners first reported a position in MYOK in Q4 2017 and held it in 8 quarters. The position peaked at $6.82M in Q2 2020. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

Eversept Partners reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Eversept Partners sold 70,594 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $6.82M.
Eversept Partners first reported a position in MyoKardia, Inc. Common Stock in Q4 2017 and held it in 8 quarters.
Eversept Partners's MyoKardia, Inc. Common Stock position peaked at $6.82M in Q2 2020.
237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Eversept Partners's 13F filing for Q3 2020, filed 12 Nov 2020.